Winners ECNP Excellence Awards 2023

P.0314
The role of eukaryotic elongation factor 1 A proteins at synapses and in synucleinopathy
Sarka Jelinkova, France

P.0207
Major psychiatric complications of psychedelic drug use: a systematic review of case reports
Betül Yildirim, Türkiye

P.0337
Prenatal antidepressant exposure and offspring brain morphology trajectories: a longitudinal population-based mri study
Dogukan Koc, The Netherlands

P.0338
Risk factors and consequences of traumatic brain injury in a Swiss male population cohort
Alexandru Pavel, Romania

P.0394
Using machine learning to improve pathways for precision medicine in psychiatry
Paris Alexandros Lalousis, United Kingdom

P.0216
Treatment adherence in forensic patients with schizophrenia spectrum disorders discharged on long-acting injectable antipsychotics – a comparative three-year mirror-image study
Yasin Hasan Balcioglu, Türkiye

P.0253
Evaluation of circadian clock proteins and the effect of continuous positive airway pressure (CPAP) treatment among obstructive sleep apnea patients
Agata Gabryelska, Poland

P.0371
Effects of ketamine and lamotrigine on negative emotional processing in the brain: a double-blind randomized controlled neuroimaging study
Marvin Meiering, Germany

P.0186
The role of microglia and progranulin in the pathophysiology of frontotemporal dementia
Marc-Philipp Weyer, Germany

P.0199
Borderline personality disorder: clinical and inflammatory features
Nadia Cattane, Italy

P.0076
Psilocybin as a treatment for anorexia nervosa: 6-week and 3-month follow-up results
Hannah Douglass, United Kingdom

P.0381
Relationship between heart rate variability and impulse control, emotion regulation, cognitive flexibility, magical ideation in controls, and major depression patients
Hayri Can Ozden, Türkiye

P.0325
Prenatal infection causes increased general anxiety in early adult rats both sexes, but has no effect on memory or sociability
Marina Manojlović, Serbia

P.0112
Pharmacogenomic-guided therapy for the improvement of antidepressant treatment outcomes: systematic review and meta-analysis of current evidence from randomised controlled trials
Filip Milosavljević, Serbia

P.0328
A generalizable normative deep learning approach for the discrimination of psychiatric disorders based on neuroanatomy
Inês Sampaio, Italy

P.0382
Elevated resting-state EEG gamma-band power in schizophrenia
Özge Akgül, Türkiye

P.0118
Mitochondrial DNA copy number, oxidation, and D-loop methylation alterations in acute or remission phases of unipolar and bipolar depression
Deniz Ceylan, Türkiye

P.0119
Increased oxidative DNA damage and altered base excision repair mechanisms in bipolar disorder and individuals at risk for bipolar disorder
Hidayet Ece Çelik, Türkiye

P.0121
Decreased mitochondrial copy number in individuals with bipolar disorder and their unaffected siblings
Izel Cemre Akşahin, Türkiye

P.0326
Anethole prevents high-calorie diet-induced brain lipid peroxidation in rats and normalizes superoxide dismutase activity
Elis Rafailova, Bulgaria

P.0063
Frequency and associated features of phantom phone signaling syndrome in youth applying to the psychiatry clinic
Zehra Uçar Hasanlı, Türkiye

P.0126
White matter microstructure in major depressive disorder is associated with lymphocyte count: differential effects of childhood maltreatment
Susanne Meinert, Germany

P.0286
Fall prevention through vestibular perceptual learning
Matthias Ertl, Switzerland

P.0330
Alterations of functional connectivity dynamics in affective and psychotic disorders
Linnea Hoheisel, Germany

P.0148
Human monocytes of patients with depression and inflammation, transdifferentiated into neuronal-like cells, show hyperresponsiveness to inflammatory stimulation
Susanne Schillo, Germany

P.0584
Altered salience/sensorimotor network activation during emotional processing in non-responders to paroxetine treatment with depression
Rita Vieira, Portugal

P.0780
Electroconvulsive therapy improves somatic symptoms before mood in patients with depression: a directed network approach
Emma De Schuyteneer, Belgium

P.0598
Structural brain network connectivity mediates the association between polygenic score for tumor necrosis factor-α and processing speed in acute depression
Jonathan Repple, Germany

P.0761
Virtual reality-based training for improvement of cognitive functioning for healthy older adults – preliminary results
Ewa Szczepocka, Poland

P.0630
Machine learning model to estimate mortality risk after the first episode of bipolar disorder
Johannes Lieslehto, Finland

P.0635
A novel marker of interleukin 6 activity and clinical and cognitive outcomes in depression
Éimear M Foley, United Kingdom

P.0788
Pharmacological treatment of psychotic depression: a systematic review and network meta-analysis
Chiara Possidente, Italy

P.0663
Steroid-responsive catatonia associated with possible autoimmune enchephalitis – a case series
Rifat Serav Ilhan, Türkiye

P.0571
Smartphone app-induced habit: a therapeutic component in psychological treatment for obsessive-compulsive disorder
Ana Maria Frota Lisboa Pereira De Souza, United Kingdom

P.0693
Unique contribution of neurotransmitter maps for predicting cerebral blood flow alterations in schizophrenia and the clinical high-risk state for psychosis
Samuel Knight, United Kingdom

P.0807
Schizophrenia-like behavior in an RNA binding motif 12 (RBM12) zebrafish model
Elena Richert, Iceland

P.0784
Electroconvulsive therapy – charge and frequency relate to therapeutic outcome
Kaan Keskin, Türkiye

P.0808
Angiotensin-converting enzyme type 2 blockade affects behavior, motor coordination, and thermal nociception in mice
Filippos - Savvas Chelmis, Bulgaria

P.0702
MRI-based cortical gray/white matter contrast in individuals with clinical or genetic risk for psychosis
Nasimeh Naseri, Norway

P.0740
Poor sleep quality is associated with abnormal white matter structure in psychotic disorders
Umit Haluk Yesilkaya, Türkiye

P.0838
Are genetics underpinning the increased risk of SARS-CoV-2 infection in people with mental disorders?
Anna Monistrol-Mula, Spain

P.0713
The effect of electroconvulsive treatment on inflammatory indices in major psychiatric disorders
Amine Kilictutan, Türkiye

P.0748
Nuclei-specific hypothalamus networks predict a dimensional marker of stress in humans
Daria EA Jensen, Germany

P.0839
Dropout of prescribed psychotherapeutic treatment among patients with anxiety disorders or major depression within the capital region of Denmark
Frederikke Hørdam-Gronemann, Denmark

P.0813
Hyperlipidemia affects synaptic integrity in the hippocampus but not cerebral cortex
Büşranur Şeker, Türkiye

P.0814
Bempedoic acid attenuates cognitive impairment and depression-like behavior in middle-aged rats
Gülşen Çelebi, Türkiye

P.0816
Social environment affects the vulnerability to adolescent-onset depression and determines antidepressant efficacy in a preclinical model
Naomi Ciano Albanese, Italy

P.0548
Effects of cannabidiol on fear conditioning in anxiety disorders: interactions with sex and antidepressant use but no enhanced fear extinction
Caroline Kwee, The Netherlands

P.0753
Gut microbiota regulates diurnal oscillations in stress responsiveness
Gabriel Tofani, Ireland

P.0819
CYP2C19 in the developing brain of transgenic humanised knock-in mouse causes morphological changes in the cerebellum, including 11.8% atrophy
Andrea Atanasov, Serbia

P.0823
Social recognition, short-term and long-term object recognition memory in CYP2C19 humanised transgenic mice
Vesna Pesic, Serbia

P.0754
The virome regulates the effects of chronic stress in mice
Nathaniel L. Ritz, Ireland

P.0858
Differences in mitochondrial DNA copy number between major depressive disorder, bipolar disorder and schizophrenia: a meta-analysis
Sevin Hun Senol, Türkiye

P.0831
Exploring psychiatric conditions through machine learning: a comprehensive analysis of large-scale data from the ECNP data network
Adyasha Khuntia, Germany

P.1090
Ketamine and the 5-HT1A receptor biased agonists, NLX-204 and NLX-101, share common cortical efficacious rapid acting antidepressant mechanisms in rat cms depression model
Piotr Gruca, Poland

P.1099
Impact of personalized dosing guided by plasma level quantification on escitalopram exposure - a cross-sectional study
Aleksandra Jeremic, Serbia

P.1101
Impact of personalised dosing based on quantification of drug plasma levels on the efficacy and safety of treatment with escitalopram
Petar Vuković, Serbia

P.1102
Stable neural underpinnings of emotional cognition subgroups in newly diagnosed patients with bipolar disorder: a prospective fMRI study
Hanne Lie Kjaerstad, Denmark

P.1104
Functional neuroimaging for the differentiation between healthy controls, depressed bipolar and major depressive patients: a machine learning study
Federico Calesella, Italy

P.1293
Etifoxine and nifedipine act synergistically to reduce directly elicited tetanic contractions in vitro
Vesela Kokova, Bulgaria

P.1365
Dynamic functional connectivity of the central autonomic network in major depressive disorder
Federica Goffi, Italy

P.1248
Exposure to prenatal stress and long-lasting effect on microbiome composition and functionality in the offspring: implications for behavioural outcomes
Floriana De Cillis, Italy

P.1072
Reward-related impulsivity as a possible surrogate marker of motivation in aging Sprague-Dawley rats
Jovana Aranđelović, Serbia

P.1252
Temporal signature of large-scale network integration in emotion regulation
Tamara De Kloe, The Netherlands

P.1253
The gut microbiome in psychiatric disorders: a transdiagnostic perspective
Danique Mulder, The Netherlands

P.1170
Sorbitol accumulation in ZDF rat’s brain as new link between diabetes and Alzheimer’s disease?
Pavol Bodo, Slovak Republic

P.1041
Early-stage adverse effects of antidepressant therapy and associated factors in an psychiatry outpatient clinic
Beren Özel, Türkiye

P.1272
The youth baby and child cohort study: automated intracranial volume segmentation in prenatal three-dimensional ultrasound using convolutional neural networks
Sonja De Zwarte, The Netherlands

P.1318
Mice with a genetic loss of vesicular glutamate transporter 3 targeted to 5-hydroxytryptamine neurons show impairments in reward-based learning
L. Sophie Gullino, United Kingdom

P.1014
Investigation of clinical risk factors associated with substance use in adults with ADHD
Berkem Karakoyunlu, Türkiye

P.1375
Cerebral serotonin 2a receptor occupancy of psychedelic and non-psychedelic compounds as measured in vivo in pigs
Clara Aabye Madsen, Denmark

P.1028
Bidirectional longitudinal associations between attention deficit hyperactivity disorder and physical health in a large cohort dataset
Claire Reed, United Kingdom

P.1225
Effort allocation for rewards in first-episode psychosis and first-episode mania
Simge Uzman Özbek, Türkiye

P.1151
Neuroanatomical network basis of memory performance in euthymic bipolar disorder
Andrea Fernandes, Ireland

P.1403
Repeated, 4-week dosing of CPL500036, a novel phosphodiesterase 10A inhibitor, does not induce tolerance to its antipsychotic-like action
Joanna Krzemień, Poland

P.1031
The relationship between iron,iron binding capacity,ferritin levels, and clinical parameters in adults with attention deficit hyperactivity disorder: a case-control study
Bilal Sağlıyan, Türkiye

P.1390
Neurodynamics of empathy and prosociality following serotonergic stimulation with an ayahuasca analogue containing N,N-dimethyltryptamine and harmine in a randomised controlled trial
Helena Aicher, Switzerland

P.1405
Study of (S)-ketamine’s effects on the dopamine dynamics using fiber photometry
Arianna Rizzo, Spain

P.1178
The intersection of the differential brain transcriptome alteration between Covid-19 and Alzheimer’s disease patients
Kamelija Horvatovic, Croatia

P.1160
Depression, anxiety and stress in individuals following the acute phase of Covid-19
Vojislava Bugarski Ignjatović, Serbia

P.1240
The association between exposome score for schizophrenia and metabolic parameters in individuals with schizophrenia and healthy controls
Gamze Erzin, Türkiye